Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 1999
Telomerase activity as a measure for monitoring radiocurability of tumor cellsS G Sawant, V Gregoire, S Dhar, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 1, 1989
Radiobiological intercomparisons of fast neutron beams used in therapyM Beauduin, J Gueulette, B M de Coster, et al.
Presse Medicale (Paris, France : 1983)|December 10, 2003
[Survey on the treatment of hospitalised community-acquired lower respiratory tract infections]P Villani, F Barlesi, A Paraponaris, et al.
Seminars in Oncology|October 1, 1993
Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapiesW Plunkett, V Gandhi, P Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphomaM J Keating, P McLaughlin, W Plunkett, et al.
Leukemia & Lymphoma|January 1, 1994
The expanding role of fludarabine in hematologic malignanciesM J Keating, S O'Brien, L E Robertson, et al.
Seminars in Oncology|October 1, 1993
New initiatives with fludarabine monophosphate in hematologic malignanciesM J Keating, S O'Brien, L E Robertson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2012
Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approachA Fairchild, R Bar-Deroma, L Collette, et al.
Contrast Media & Molecular Imaging|October 26, 2010
Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell deathK A Radermacher, S Boutry, S Laurent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931Z S Zumsteg, M Luu, C Fortpied, et al.
Pageof 3